CurrentmediviewcurativePolicy MM-PNP-056

Reduction Mammoplasty and Gynecomastia Surgery (Breast Reduction) Coverage Criteria

Customize your policy alerts

Sign up for mediviewcurative Policy MM-PNP-056 alerts

Get alerted when Policy MM-PNP-056 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Criteria and medical necessity guidance for authorization of reduction mammoplasty and gynecomastia surgery for members; applies to Medical Utilization Management reviewers and providers requesting authorization.

Policy Summary

Payermediviewcurative

PolicyReduction Mammoplasty and Gynecomastia Surgery (Breast Reduction) Coverage Criteria

Policy CodePolicy MM-PNP-056

Change TypeNo material change

Effective DateApr 12, 2024

Next Review Date

Key ActionObtain prior authorization with physician prescription, high-quality frontal and side photographs, and surgeon's estimated grams of tissue to be removed per breast.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

18+minimum age for reduction mammoplasty (women)

>=3 morequired conservative therapy trial

1 yrsymptom duration affecting daily activities

1 kgthreshold note: per-breast weight

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentmediviewcurativePolicy MM-PNP-056

Reduction Mammoplasty and Gynecomastia Surgery (Breast Reduction) Coverage Criteria

Customize your policy alerts

Sign up for mediviewcurative Policy MM-PNP-056 alerts

Get alerted when Policy MM-PNP-056 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

Payermediviewcurative

PolicyReduction Mammoplasty and Gynecomastia Surgery (Breast Reduction) Coverage Criteria

Policy CodePolicy MM-PNP-056

Change TypeNo material change

Effective DateApr 12, 2024

Next Review Date

Key ActionObtain prior authorization with physician prescription, high-quality frontal and side photographs, and surgeon's estimated grams of tissue to be removed per breast.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

18+minimum age for reduction mammoplasty (women)

>=3 morequired conservative therapy trial

1 yrsymptom duration affecting daily activities

1 kgthreshold note: per-breast weight

2required photo views

4related policy refs

Coverage Criteria for Reduction Mammoplasty and Gynecomastia Surgery

Macromastia (Reduction Mammoplasty) medical necessity

Covered when ALL of the following are met for reduction mammoplasty (macromastia):

Eligibility: Member is female aged 18 or older, or growth is complete (breast size stable over one year)

Symptom requirement: Member has persistent symptoms in at least two anatomical areas (headaches; neck pain; shoulder pain; upper back pain; painful kyphosis documented by X-rays; bra strap injury causing pain/discomfort/ulceration; skin breakdown such as severe soft tissue infection, tissue necrosis, ulceration, or hemorrhage) directly attributed to macromastia and affecting daily activities for at least 1 year1 year

Additional signs: Upper extremity paresthesia

Documentation and likelihood: Severe breast hypertrophy documented by high-quality color frontal and side photographs; reasonable likelihood that symptoms are primarily due to macromastia; reduction likely to improve chronic pain

Conservative therapy: Pain and related symptoms persist despite at least a 3-month trial of therapeutic measures (analgesics/NSAIDs and/or muscle relaxants; dermatologic therapy for ulcers/necrosis/refractory infection; physical therapy/exercises/posturing; supportive devices such as proper wide-strapped bras; chiropractic or osteopathic manipulative treatment; medically supervised weight loss; orthopedic or spine evaluation)>=3 months

Imaging for older women: Women 50 years of age or older have a negative mammogram performed within the two years prior to planned surgerymammogram within 2 years

Tissue removal estimate: Surgeon documents estimated grams of breast tissue to be removed from each breast based on body surface area (Mosteller formula); note that reduction may be considered regardless of BSA if >1 kg of breast tissue will be removed per breast>1 kg exception

Surgeon-estimated tissue removal must be documented

Gigantomastia of pregnancy

Covered when ALL of the following are met for gigantomastia of pregnancy:

Pregnancy complication: Gigantomastia of pregnancy accompanied by massive infection, significant hemorrhage, tissue necrosis with slough, or ulceration of breast tissue, and delivery is not imminent

Cosmetic and Not Medically Necessary indications

Gynecomastia and cosmetic: Gynecomastia surgery (breast reduction, surgical mastectomy, or liposuction), unilateral or bilateral, is considered cosmetic; medical therapy should be aimed at correcting reversible causes (e.g., discontinuing causative drugs); there is insufficient evidence that surgery is superior to conservative management for pain due to gynecomastia

Procedures for gynecomastia are cosmetic for indications not listed in section I

Asymptomatic reduction: Reduction mammoplasty performed for asymptomatic members is considered cosmetic

Chronic dermatologic conditions in the infra-mammary fold (such as intertrigo, eczema, dermatitis, and/or ulceration) alone do not constitute a medically necessary indication for reduction mammoplasty. To be considered as part of medical necessity, the infra‑mammary condition must be unresponsive to dermatologic treatments and conservative measures for at least 6 months and the member must also meet the other macromastia criteria in Section I (e.g., persistent symptoms in multiple anatomic areas, functional impairment, documentation and conservative therapy requirements).

The following procedures and procedural combinations are considered experimental, investigational, or unproven and are not eligible for coverage: combined arthroscopic shaver and liposuction for adolescent gynecomastia, liposuction-only reduction mammoplasty, radiotherapy for prevention or management of gynecomastia recurrence, and vacuum-assisted breast biopsy system for treatment of gynecomastia.

In addition, gynecomastia surgery (including reduction, surgical mastectomy, or liposuction) is considered cosmetic for indications not expressly listed as medically necessary in Section I. Requests for procedures that are cosmetic in nature will be denied; medical therapy to address reversible causes (for example, discontinuation of an offending drug) should be attempted prior to any surgical intervention.

Coding and Tissue-Removal Guidance

Covered/authorization-related codesmixed

affected codes

surgeon-estimated tissue removal documentation and photographic evidence required (codes not specified in this part)

Experimental/InvestigationalmixedExperimental

experimental

Combined arthroscopic shaver and liposuction for the treatment of adolescent gynecomastia; Liposuction-only reduction mammoplasty; Radiotherapy for the prevention or management of gynecomastia recurrence; Vacuum-assisted breast biopsy system for treatment of gynecomastia.

Breast tissue removal per breast — estimation and threshold

Surgeon estimation methodSurgeon estimates grams of breast tissue to be removed from each breast based on body surface area (Mosteller formula).

Exception thresholdIf more than 1 kg (1000 grams) of breast tissue is to be removed from a single breast, the procedure may be considered medically necessary regardless of BSA-based estimate.

Tissue type specifiedEstimate applies to breast tissue (not fatty tissue).

Documentation requirementSurgeon must document the estimated grams to be removed per breast in the authorization submission.

Prior Authorization, Documentation, and Provider Requirements

Prior Authorization

Prior authorization required and evaluated against medical necessity

Prior authorization is required for reduction mammoplasty and is evaluated against the policy's medical necessity criteria including age/growth completion, symptom requirements, documented trial of conservative therapies (≥3 months), photographic documentation, and the surgeon's estimated tissue removal per breast.

Authorization will be assessed against the macromastia criteria in Section I (age or growth complete, symptom documentation, conservative therapy trial, imaging when applicable).
Surgeon must estimate grams of breast tissue to be removed per breast (BSA/Mosteller-based) or meet the >1 kg per breast exception.

Prior Authorization

Include physician prescription and high-quality photos with prior auth

Submit prior authorization with a physician-written prescription and high-quality color frontal and side photographs to support medical necessity for reduction mammoplasty or gynecomastia surgery requests.

Photographs must be high-quality color frontal-view and side-view images.

Background

Reduction mammoplasty (breast reduction) is performed to relieve the symptoms of macromastia, where excessive breast volume causes functional impairment such as neck, shoulder, or upper back pain; bra‑strap injury; skin breakdown; or painful kyphosis. Medical necessity is established when symptoms are persistent and impact daily activities for at least 1 year, when symptoms affect multiple anatomic areas (or include upper‑extremity paresthesia), and when a trial of conservative therapy (at least 3 months) has failed to provide sufficient relief. Documentation should include high‑quality color frontal and side photographs and a surgeon’s estimate of breast tissue to be removed per breast (based on body surface area), noting that removal of >1 kg per breast may qualify regardless of body surface area.

Key Definitions

Macromastia (marked breast hypertrophy) — definition

DefinitionMarked breast hypertrophy causing persistent symptoms in multiple anatomical areas (e.g., headaches; neck, shoulder, or upper back pain; painful kyphosis documented by X-rays; bra strap injury; skin breakdown such as severe soft tissue infection, tissue necrosis, ulceration or hemorrhage) that affect daily activities for at least 1 year.

Required symptom durationSymptoms must affect daily activities for at least 1 year.

Anatomic scopePersistent symptoms must be present in at least two anatomical areas listed (headaches; neck; shoulders; upper back; kyphosis; bra strap injury; skin breakdown).

Conservative therapy prior to surgeryPain must persist despite at least a 3-month trial of conservative measures (e.g., NSAIDs, dermatologic therapy, physical therapy, supportive devices, chiropractic/osteopathic care, medically supervised weight loss, orthopedic/spine evaluation).

Gigantomastia of pregnancy — definition

Policy Summary

Payermediviewcurative

PolicyReduction Mammoplasty and Gynecomastia Surgery (Breast Reduction) Coverage Criteria

Policy CodePolicy MM-PNP-056

Change TypeNo material change

Effective DateApr 12, 2024

Next Review Date

Key ActionObtain prior authorization with physician prescription, high-quality frontal and side photographs, and surgeon's estimated grams of tissue to be removed per breast.

SourceLink

On This Page

A physician prescription must accompany the images in the authorization submission.

Step Therapy

Document ≥3-month trial of conservative therapies before surgery

Document and demonstrate a trial of conservative therapies for at least 3 months with persistent symptoms prior to approval for reduction mammoplasty.

Conservative measures include NSAIDs/analgesics, dermatologic therapy, physical therapy/exercises, supportive devices (e.g., proper bra support), chiropractic/osteopathic treatment, medically supervised weight loss, and orthopedic/spine evaluation.
The 3-month trial must be documented by the physician and show insufficient relief of symptoms.

Note

Ensure complete submission of all policy-required documentation

Provide all requested authorization materials and documentation demonstrating the medical indications specified in Section I; incomplete submissions may delay review or result in denial.

Ensure documentation addresses age/growth completion, symptom duration and severity, conservative therapy trial, required imaging for women ≥50, and surgeon's tissue removal estimate.
Include the high-quality frontal and side photographs and physician prescription described in the documentation requirements.

Documentation Required

Physician prescription, front & side photos, and surgeon's grams-removed estimate required

Required documentation for authorization includes a physician prescription, high-quality color frontal and side photographs, and the surgeon's documented estimate of grams of breast tissue to be removed per breast based on BSA (Mosteller formula); note the >1 kg per breast exception.

Surgeon must document estimated grams of breast tissue (not fatty tissue) to be removed from each breast using BSA (Mosteller) calculations.
Breast reduction may be medically necessary regardless of BSA if >1 kg per breast will be removed.

Documentation Required

Physician-written prescription and photos required for gynecomastia

For gynecomastia requests, submit a physician-written prescription and high-quality color frontal and side photographs documenting the condition as part of the authorization package.

Documentation requirement mirrors that for macromastia: physician prescription plus high-quality frontal and side photos.

Denial Risk

Gynecomastia procedures are considered cosmetic when indications are not listed

Gynecomastia surgery (reduction, mastectomy, or liposuction) is considered cosmetic for indications not listed in Section I; requests for cosmetic indications will be denied.

Medical therapy to correct reversible causes (e.g., drug discontinuance) should be attempted prior to surgical requests.
There is insufficient evidence that surgical removal is more effective than conservative management for pain from gynecomastia.

Denial Risk

Documentation omission may result in denial

Failure to provide the physician-written prescription and high-quality frontal and side photographs as required may lead to denial of coverage.

Ensure images and prescription are included in the authorization submission to avoid documentation-related denial.

DefinitionPregnancy-associated extreme breast enlargement (gigantomastia of pregnancy) accompanied by complications such as massive infection, significant hemorrhage, tissue necrosis with slough, or ulceration of breast tissue when delivery is not imminent.

Associated complicationsMassive infection; significant hemorrhage; tissue necrosis with slough; ulceration of breast tissue.

Timing considerationCovered only when delivery is not imminent.